Insight Molecular Diagnostics (IMDX) Share-based Compensation (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Share-based Compensation of $615000.0 for Q1 2026, down 14.7% sequentially from $721000.0 in Q4 2025, and up 30.02% YoY from $473000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Share-based Compensation (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Share-based Compensation data on file, last reported at $615000.0 in Q1 2026.
- Quarterly Share-based Compensation rose 30.02% year-over-year to $615000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 30.59% YoY) and the FY2025 annual result came in at $2.2 million, up 26.58% from the prior year.
- Share-based Compensation slipped to $615000.0 in Q1 2026 per IMDX's latest filing, from $721000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $3.2 million in Q3 2022, with the low at $386000.0 in Q2 2024.
- Average Share-based Compensation over 5 years is $1.0 million, with a median of $608000.0 recorded in 2023.
- Year-over-year, Share-based Compensation jumped 71.95% in 2022 and tumbled 81.52% in 2023.
- Insight Molecular Diagnostics' Share-based Compensation stood at $2.6 million in 2022, then plunged by 81.52% to $484000.0 in 2023, then rose by 3.1% to $499000.0 in 2024, then surged by 44.49% to $721000.0 in 2025, then declined by 14.7% to $615000.0 in 2026.
- Business Quant data shows IMDX's Share-based Compensation at $615000.0 in Q1 2026, $721000.0 in Q4 2025, and $521000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 20.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 83.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 58.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 16.34 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 95.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 32.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 65.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 60.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 5.47 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 615,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 615,000.00 |
| Mar 31, 2026 | 615,000.00 |
| Dec 31, 2025 | 721,000.00 |
| Dec 31, 2025 | 721,000.00 |
| Sep 30, 2025 | 521,000.00 |
| Sep 30, 2025 | 521,000.00 |
| Jun 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 504,000.00 |
| Mar 31, 2025 | 473,000.00 |
| Mar 31, 2025 | 473,000.00 |
| Dec 31, 2024 | 499,000.00 |
| Dec 31, 2024 | 499,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Mar 31, 2024 | 418,000.00 |
| Mar 31, 2024 | 418,000.00 |
| Dec 31, 2023 | 484,000.00 |
| Dec 31, 2023 | 484,000.00 |